AERI

Aerie Pharmaceuticals, Inc. - Common Stock

$59.00 -$1.15 -1.95%



Shares Bought10
Shares Sold10
Total20
Shares Owned0
Last Price$59.00
Total Return$79.77
Range Today$58.90 - $61.05
52 Week Range$35.50 - $66.60
Open$60.30
Market Cap$2.19B
Volume/Average214.63K/502.61K
P/E Ratio-
Dividend/Yield-




Aerie Pharmaceuticals, Inc. is a clinical stage pharmaceutical company. It focuses on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The company's product candidates are Rhopressa and Roclatan. Aerie Pharmaceuticals was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem and Eric J. Toone on June 22, 2005 and is headquartered in Irvine, CA.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
10-05-17 13:28 10-13-17 18:20 $54.95 $65.75 +$10.80 +19.65% unholyurinal
10-02-17 16:51 10-13-17 18:20 $49.04 $65.75 +$16.71 +34.07% nekochan16
10-02-17 16:52 10-13-17 18:20 $49.09 $65.75 +$16.66 +33.94% nekochan16
10-02-17 16:54 10-13-17 18:20 $49.09 $65.75 +$16.66 +33.94% crizisaround nekochan16
10-02-17 15:42 10-06-17 13:30 $48.89 $53.95 +$5.06 +10.35% nekochan16
09-12-17 18:23 09-13-17 13:28 $55.64 $55.05 -$0.59 -1.06% ahze85283 nekochan16 grifftenstein
09-12-17 18:25 09-13-17 13:28 $55.75 $55.05 -$0.70 -1.26% crizisaround ahze85283 nekochan16 grifftenstein
10-02-17 16:53 10-13-17 18:20 $49.09 $65.75 +$16.66 +33.94% nekochan16
09-12-17 18:22 09-13-17 13:28 $55.64 $55.05 -$0.59 -1.06% crizisaround ahze85283 nekochan16 grifftenstein
09-12-17 18:26 09-13-17 13:28 $55.95 $55.05 -$0.90 -1.60% ahze85283